Abstract
Neuroblastoma is a pediatric solid tumor with high expression of the tumor associated antigen disialoganglioside GD2. Despite initial response to induction therapy, nearly 50% of high-risk neuroblastomas recur because of chemoresistance. Here we encapsulated the topoisomerase-I inhibitor SN-38 in polymeric nanoparticles (NPs) surface-decorated with the anti-GD2 mouse mAb 3F8 at a mean density of seven antibody molecules per NP. The accumulation of drug-loaded NPs targeted with 3F8 versus with control antibody was monitored by microdialysis in patient-derived GD2-expressing neuroblastoma xenografts. We showed that the extent of tumor penetration by SN-38 was significantly higher in mice receiving the targeted nano-drug delivery system when compared to non-targeted system or free drug. This selective penetration of the tumor extracellular fluid translated into a strong anti-tumor effect prolonging survival of mice bearing GD2-high neuroblastomas in vivo.
Keywords:
GD2-targeted nanoparticles; Intratumor drug distribution; Irinotecan (PubChem CID: 60838).; Irinotecan/SN-38; Microdialysis; Neuroblastoma; PDX models; SN-38 (PubChem CID: 104842); Tumor extracellular fluid.
Copyright © 2017 Elsevier B.V. All rights reserved.
MeSH terms
-
Animals
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal / chemistry
-
Antibodies, Monoclonal, Murine-Derived
-
Antigens, Neoplasm / genetics
-
Antigens, Neoplasm / metabolism
-
Antineoplastic Agents, Phytogenic / administration & dosage*
-
Antineoplastic Agents, Phytogenic / chemistry
-
Antineoplastic Agents, Phytogenic / pharmacokinetics
-
Camptothecin / administration & dosage
-
Camptothecin / analogs & derivatives*
-
Camptothecin / chemistry
-
Camptothecin / pharmacokinetics
-
Cell Line, Tumor
-
Child, Preschool
-
Drug Liberation
-
Extracellular Fluid / metabolism*
-
Gene Expression Regulation, Neoplastic
-
Humans
-
Immunoglobulin G / administration & dosage*
-
Immunoglobulin G / chemistry
-
Irinotecan
-
Male
-
Mice, Nude
-
N-Acetylgalactosaminyltransferases / antagonists & inhibitors*
-
N-Acetylgalactosaminyltransferases / genetics
-
N-Acetylgalactosaminyltransferases / immunology
-
N-Acetylgalactosaminyltransferases / metabolism
-
Nanoparticles / administration & dosage*
-
Nanoparticles / chemistry
-
Neuroblastoma / drug therapy
-
Neuroblastoma / metabolism*
-
Tissue Distribution
-
Xenograft Model Antitumor Assays
Substances
-
3F8 antibody
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
Antigens, Neoplasm
-
Antineoplastic Agents, Phytogenic
-
Immunoglobulin G
-
Irinotecan
-
N-Acetylgalactosaminyltransferases
-
(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase
-
Camptothecin